Clene to Showcase at the Emerging Growth Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 20 2025
0mins
Source: Globenewswire
Clene Inc. Presentation: Clene Inc. will present at the Emerging Growth Conference on October 23, 2025, at 3:10 p.m. ET, focusing on their advancements in treating neurodegenerative diseases through mitochondrial health improvement.
Company Overview: Clene is a clinical-stage biopharmaceutical company based in Salt Lake City, specializing in therapies for diseases like ALS and MS, with their investigational product CNM-Au8® targeting mitochondrial function and oxidative stress reduction.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
